In this episode of Denatured, you'll be hearing from Edoardo Negroni, co-founder & managing partner at AurorA-TT and Naveed Siddiqi, senior partner, Venture Investments at Novo Holdings. We debate whether Europe’s world-class science can be matched by a truly integrated venture ecosystem—and what it would take, in practice, to get there.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsEdoardo Negroni, Co-Founder & Managing Partner, AurorA-TTNaveed Siddiqi, Senior Partner, Venture Investments, Novo HoldingsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
What makes life science angel investment work?
Q1 earnings take off, Lilly strikes deals, Regeneron notches historic approval, FDA raises questions
The next era of diabetes management
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
Free AI-powered recaps of BioSpace and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.